Not Yet Recruiting
IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
NCT07672483
- Conditions
- Refractory Solid Tumor Malignancies, Relapsed Solid Tumor Malignancies
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States